High flow nasal cannula (HFNC) has been shown to improve ventilation and oxygenation and reduce work of breathing in newborns with respiratory distress. Heliox, decreases resistance to airflow, reduces the work of breathing, facilitates the distribution of inspired gas, and has been shown to attenuate lung inflammation during the treatment of acute lung injury.
HYPOTHESIS:
Heliox delivered by HFNC will decrease resistive load, decrease work of breathing, improve ventilation and attenuate lung inflammation during spontaneous breathing following acute lung injury in the newborn pig.
METHODS:
Spontaneously breathing neonatal pigs received Nitrox or Heliox by HFNC and studied over 4 hrs following oleic acid injury. Gas exchange, pulmonary mechanics and systemic inflammation were measured serially. Lung inflammation biomarkers were assessed at termination.
RESULTS:
Heliox breathing animals demonstrated lower work of breathing reflected by lower tracheal pressure, phase angle and phase relationship. Ventilation efficiency index was greater compared to Nitrox. Heliox group showed less lung inflammation reflected by lower tissue interleukin-6 and 8.
CONCLUSION:
High flow nasal Heliox decreased respiratory load, reduced resistive work of breathing indices and attenuated lung inflammatory profile while ventilation was supported at less pressure effort in the presence of acute lung injury.
JobeAH,
IkegamiM.
Mechanisms initiating lung injury in the preterm.
Early Hum Dev1998;
53
(1):
81–
94.
2.
NorthwayWHJr.,
RosaRC,
PorteDY.
Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.
N Engl J Med1967;
276
(7):
357–
368.
3.
DeorasKS,
GreenspanJS,
WolfsonMR,
KeklikianEN,
ShafferTH,
AllenJL.
Effects of inspiratory resistive loading on chest wall motion and ventilation: Differences between preterm and full-term infants.
Pediatr Res1992;
32
(5):
589–
594.
4.
GreenspanJS,
MillerTL,
ShafferTH.
The neonatal respiratory pump: A developmental challenge with physiologic limitations.
Neonatal Netw2005;
24
(5):
15–
22.
5.
AllenJL,
WolfsonMR,
McDowellK,
ShafferTH.
Thoracoabdominal asynchrony in infants with airflow obstruction.
Am Rev Respir Dis1990;
141
(2):
337–
342.
6.
BarachAL.
The Therapeutic Use of Helium.
JAMA1936;
107
(16):
1273–
1280.
7.
MiglioriC,
GanciaP,
GarzoliE,
SpinoniV,
ChiricoG.
The Effects of helium/oxygen mixture (heliox) before and after extubation in long-term mechanically ventilated very low birth weight infants.
Pediatrics2009;
123
(6):
1524–
1528.
8.
JassarRK,
VellankiH,
ZhuY,
HesekA,
WangJ,
RodriguezE,
et al.
High flow nasal cannula (HFNC) with Heliox decreases diaphragmatic injury in a newborn porcine lung injury model.
Pediatr Pulmonol2014;
49
(12):
1214–
1222.
9.
ColnaghiM,
PierroM,
MiglioriC,
CiralliF,
MatassaPG,
VendettuoliV,
et al.
Nasal continuous positive airway pressure with heliox in preterm infants with respiratory distress syndrome.
Pediatrics2012;
129
(2):
e333–
e338.
10.
Martinon-TorresF.
Noninvasive ventilation with helium-oxygen in children.
J Crit Care2012;
27
(2):
220e1–
e9.
11.
NawabUS,
TouchSM,
Irwin-ShermanT,
BlacksonTJ,
GreenspanJS,
ZhuG,
et al.
Heliox attenuates lung inflammation and structural alterations in acute lung injury.
Pediatr Pulmonol2005;
40
(6):
524–
532.
12.
HessDR,
FinkJB,
VenkataramanST,
KimIK,
MyersTR,
TanoBD.
The history and physics of heliox.
Respir Care2006;
51
(6):
608–
612.
13.
BarachAL,
EckmanM.
The Effects of Inhalation of Helium Mixed with Oxygen on the Mechanics of Respiration.
J Clin Invest1936;
15
(1):
47–
61.
14.
OtisAB,
BembowerWC.
Effect of gas density on resistance to respiratory gas flow in man.
J Appl Physiol1949;
2
(6):
300–
306.
JobeAH,
KramerBW,
MossTJ,
NewnhamJP,
IkegamiM.
Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs.
Pediatr Res2002;
52
(3):
387–
392.
17.
FrizzolaM,
MillerTL,
RodriguezME,
ZhuY,
RojasJ,
HesekA,
et al.
High-flow nasal cannula: Impact on oxygenation and ventilation in an acute lung injury model.
Pediatr Pulmonol2011;
46
(1):
67–
74.
18.
SaslowJG,
AghaiZH,
NakhlaTA,
HartJJ,
LawryshR,
StahlGE,
et al.
Work of breathing using high-flow nasal cannula in preterm infants.
J Perinatol2006;
26
(8):
476–
480.
19.
DysartK,
MillerTL,
WolfsonMR,
ShafferTH.
Research in high flow therapy: Mechanisms of action.
Respir Med2009;
103
(10):
1400–
1405.
20.
LockeRG,
WolfsonMR,
ShafferTH,
RubensteinSD,
GreenspanJS.
Inadvertent administration of positive end-distending pressure during nasal cannula flow.
Pediatrics1993;
91
(1):
135–
138.
21.
MillerTL,
BlacksonTJ,
ShafferTH,
TouchSM.
Tracheal gas insufflation-augmented continuous positive airway pressure in a spontaneously breathing model of neonatal respiratory distress.
Pediatr Pulmonol2004;
38
(5):
386–
395.
22.
WolfsonMR,
HirschlRB,
JacksonJC,
GauvinF,
FoleyDS,
LammWJ,
et al.
Multicenter comparative study of conventional mechanical gas ventilation to tidal liquid ventilation in oleic acid injured shee. ASAIO J2008;
54
(3):
256–
269.
23.
NotterRH,
EganEA,
KwongMS,
HolmBA,
ShapiroDL.
Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: Effects of dose, dispersion technique, and gestational age.
Pediatr Res1985;
19
(6):
569–
577.
SzczapaT,
GadzinowskiJ.
Use of heliox in the management of neonates with meconium aspiration syndrome.
Neonatology2011;
100
(3):
265–
270.
32.
Network SSGotEKSNNR,
CarloWA,
FinerNN,
WalshMC,
RichW,
GantzMG,
et al.
Target ranges of oxygen saturation in extremely preterm infants.
N Engl J Med2010;
362
(21):
1959–
1969.
33.
SinghausCJ,
UtidjianLH,
AkinsRE,
MillerTL,
ShafferTH,
TouchSM.
Growth and development in a heliox incubator environment: A long-term safety study.
Neonatology2007;
91
(1):
28–
35.
34.
BagchiA,
ViscardiRM,
TaciakV,
EnsorJE,
McCreaKA,
HasdayJD.
Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia.
Pediatr Res1994;
36
(2):
244–
252.
35.
BarsigJ,
KustersS,
VogtK,
VolkHD,
TiegsG,
WendelA.
Lipopolysaccharide-induced interleukin-10 in mice: Role of endogenous tumor necrosis factor-alpha.
Eur J Immunol1995;
25
(10):
2888–
2893.
